3.27
0.10 (3.15%)
| Previous Close | 3.17 |
| Volume | 72,436 |
| Price / Sales | 1.89 |
| Price / Book | 3.19 |
| 52 Weeks Range |
| Profit Margin | 5.16% |
| Operating Margin (TTM) | 11.60% |
| Diluted EPS (TTM) | 0.080 |
| Quarterly Revenue Growth (YOY) | 38.50% |
| Total Debt/Equity (MRQ) | 14.28% |
| Current Ratio (MRQ) | 5.92 |
| Operating Cash Flow (TTM) | -2.03 M |
| Levered Free Cash Flow (TTM) | -1.57 M |
| Return on Assets (TTM) | 4.16% |
| Return on Equity (TTM) | 9.17% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Nephros, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.3 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Relative Valuation | NA |
| Financial Health | 1.1 |
| Macro Environment | -0.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -0.35 |
Select this tab to load the latest available analysis.
|
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Insiders | 11.19% |
| % Held by Institutions | 44.01% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Cornerstone Capital, Inc. | 30 Jun 2026 | 128,700 |
| Mesirow Financial Investment Management, Inc. | 30 Jun 2026 | 60,000 |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |